Paracetamol Market to Grow by USD 1.07 Billion (2025-2029), Boosted by Its Significant Use as an API in OTC Drugs, with Market Insights Powered by AI - Technavio

NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global paracetamol market size is estimated to grow by USD 1.07 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of  10%  during the forecast period. Significant use of paracetamol as API in large number of OTC drugs is driving market growth, with a trend towards rising preference for extended release formulations. However, growing concerns over adverse effects of analgesics  poses a challenge. Key market players include Anhui Fubore Pharmaceutical And Chemical Co. Ltd., Anqiu Luan Pharmaceutical Co. Ltd., ATABAY KIMYA SANAYI TICARET AS, Biological E. Ltd., Cipla Inc., Granules India Ltd., GSK Plc, Mallinckrodt Plc, Sanofi SA, SEQENS GROUP, Sri Krishna Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Trugen Pharmaceuticals Pvt Ltd., Zhejiang Kangle Pharmaceutical Co. Ltd., and Zhengzhou Sino Chemical Co. Ltd..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Market Driver

The Paracetamol Market is witnessing significant growth due to its widespread use as an over-the-counter (OTC) analgesic and antipyretic in various indicative diseases like headaches, flu, menstrual periods, toothaches, backaches, osteoarthritis, fever, migraines, and other aches and pains. In tropical areas and the Northern Hemisphere, the market is particularly active during influenza season. NHS and MOHFW in the UK and regulatory authorities like WHO GISRS laboratories monitor the quality of Paracetamol, ensuring its availability as an essential drug. Local market players like Seqens, Upsa, Biological E, and others manufacture Paracetamol in various forms such as Capsule, Liquid Suspension, Powder, Rectal, Intravenous, and Intravenous Paracetamol. Paracetamol is used for pain management in chronic diseases like diabetes, epilepsy, asthma, and cancer, making it a crucial treatment option for pain relief. Paracetamol is also used in veterinary applications. The market's longevity is attributed to its effectiveness in treating high temperatures and various pain indications, including postoperative pain and influenza epidemics. 

The demand for over-the-counter (OTC) analgesic drugs, including paracetamol-based medications, is growing due to ongoing research and development efforts. Manufacturers of combination drugs present significant opportunities for paracetamol API vendors. Drug companies focus on creating new paracetamol-based OTC drugs with improved formulations, adhering to regulatory requirements. These initiatives lead to new drug approvals and launches, boosting sales for both drug manufacturers and paracetamol vendors. With an increasing number of product launches and approvals, the forecast period is expected to see a rise in paracetamol purchases by drug manufacturers. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

 Market Challenges

• The Paracetamol Market faces several challenges in various regions like the NHS and MOHFW in essential drugs procurement. Local manufacturing by players like Seqens is crucial in tropical areas and Northern Hemisphere's influenza season. Paracetamol, an OTC analgesic and antipyretic, is used for headaches, flu, toothaches, menstrual periods, and other indicative diseases. Regulatory authorities like WHO GISRS laboratories monitor viruses like influenza and common cold, requiring pain and fever relief drugs. Local market players produce acetaminophen in various forms, including Capsule, Liquid Suspension, Powder, Rectal, Intravenous, and Intravenous Paracetamol. Chronic diseases like migraines, diabetes, epilepsy, asthma, and oral diseases require long-term treatment management. Paracetamol competes with other pain relief options like ibuprofen and treatment management for chronic diseases, cancer, cardiovascular diseases, and postoperative pain. Biological E and Upsa are significant players in Veterinary Drug Grade and Acetaminophen Grade production. The elderly population's increasing demand for pain relief and chronic diseases' prevalence drive market growth.
• Paracetamol, an over-the-counter analgesic, is widely used for pain relief worldwide. However, misuse or overdose can lead to adverse effects, ranging from mild to severe. Vendors are investing in developing drugs with minimal side effects to mitigate risks. Individual responses to drugs can vary, increasing the possibility of side effects for certain patients. This potential for side effects may influence prescribing practices, potentially reducing the use of specific analgesics. It is crucial for healthcare professionals to closely monitor patients and ensure proper usage to minimize risks associated with paracetamol and other analgesics.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This paracetamol market report extensively covers market segmentation by  

1. Application 
• 1.1 Surgical
• 1.2 Non-surgical
2. Formulation 
• 2.1 Powder
• 2.2 Granules
3. Geography 
• 3.1 North America
• 3.2 Europe
• 3.3 Asia
• 3.4 Rest of World (ROW)

1.1 Surgical-  The surgical segment of the global paracetamol market refers to the use of paracetamol in surgical settings for pain management. For decades, paracetamol has been a preferred choice due to its safety profile and ability to provide pain relief without the risks of addiction or respiratory depression linked to opioids. It is administered intravenously or orally to manage postoperative pain. Paracetamol is particularly effective for mild to moderate pain and can reduce the need for opioids. The surgical segment can be segmented by surgical specialties, with orthopedic surgery being a significant user. The increasing volume of surgical procedures worldwide and the emphasis on effective pain management to enhance patient outcomes are driving the growth of this segment in the global paracetamol market. Paracetamol's safety profile makes it a popular choice for patients at higher risk of opioid-related adverse events.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

Paracetamol, also known as acetaminophen, is a common over-the-counter pain reliever and antipyretic used to manage various types of pain and fever. It is available in different forms, including powder, rectal, and intravenous. In France, the Reliance program ensures the availability and affordability of essential medicines like paracetamol. The regulatory authority closely monitors its production and distribution to ensure safety and efficacy. Paracetamol is effective in managing chronic daily migraines, chronic pain, and other conditions like flu, menstrual periods, toothaches, backaches, and osteoarthritis. It is particularly beneficial for the elderly due to its long-term safety and effectiveness. The Migraine Trust, a leading organization, recommends paracetamol as a first-line treatment for migraines. Paracetamol is often compared to other pain management drugs like ibuprofen. While both are effective, paracetamol is generally considered safer for long-term use and is less likely to cause gastrointestinal side effects. Intravenous paracetamol is used in hospitals for severe cases and is effective in managing high fevers and post-surgery pain. Overall, paracetamol plays a crucial role in healthcare infrastructure and is a widely used medication for pain and fever management.

Market Research Overview

Paracetamol Market: An Overview The Paracetamol Market refers to the global trade of Paracetamol, also known as acetaminophen, which is a commonly used over-the-counter (OTC) analgesic and antipyretic. It is an essential drug used for pain management and fever reduction in various indicative diseases such as headaches, menstrual periods, toothaches, backaches, osteoarthritis, and high temperatures. Paracetamol is also used for treating conditions like migraines, flu, and common cold. Paracetamol is manufactured locally in many countries, including Seqens, and is available in various forms such as capsules, liquid suspensions, powders, rectal, intravenous, and intravenous paracetamol. The market caters to both human and veterinary applications. Regulatory authorities like the NHS (National Health Service) and MOHFW (Ministry of Health and Family Welfare) in the Northern Hemisphere and WHO GISRS laboratories monitor the production and quality of Paracetamol. The market includes local market players, Biological E, Upsa, and others, producing Acetaminophen Grade and Veterinary Drug Grade. Paracetamol is used for treating chronic diseases like diabetes, epilepsy, asthma, and cancer, as well as postoperative pain, influenza, and influenza epidemics. It is also used for pain relief in chronic diseases and treatment management in cardiovascular diseases. Paracetamol is a preferred treatment option for various conditions due to its long-term safety and efficacy, especially for the elderly and those suffering from chronic pain. Paracetamol is used for treating various conditions, including fever, aches and pains, and inflammation caused by viruses like influenza viruses and common cold. It is also used for treating pain and fever in OTC cough medicines. Paracetamol is widely used in tropical areas and during the influenza season. The Paracetamol Market has a significant commercial production capacity, with installed capacity exceeding 1 million metric tons per year. The market is expected to grow due to the increasing demand for pain relief medications and the expanding healthcare infrastructure. Paracetamol's versatility and long-term safety make it a preferred treatment option for various conditions, making it an essential component of the pharmaceutical industry.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

• Application
• Surgical
• Non-surgical
• Formulation
• Powder
• Granules
• Geography
• North America
• Europe
• Asia
• Rest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio